Market revenue in 2020 | USD 39.4 million |
Market revenue in 2028 | USD 71.4 million |
Growth rate | 7.7% (CAGR from 2020 to 2028) |
Largest segment | External beam radiationtherapy |
Fastest growing segment | Internal Beam Radiation Therapy |
Historical data | 2017 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
External beam radiationtherapy was the largest segment with a revenue share of 78.68% in 2020. Horizon Databook has segmented the Saudi Arabia radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
Saudi Arabia is estimated to grow at a high CAGR over the forecast period owing to various factors such as increase in research initiatives. For instance, in October 2019, King Abdullah University of Science and Technology (KAUST) and King Abdul Aziz University (KAU) collaborated for funding and research of innovative cancer treatment.
Furthermore, rising prevalence of cancer is anticipated to drive the market growth. According to WHO (2018), the 5- year prevalence of cancer was 70,819 in Saudi Arabia. Moreover, there is an unmet need for cancer treatment in the region.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account